Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

NCT03051607 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

66

Enrollment

INDUSTRY

Sponsor class

Stopped New Safety Information

Conditions

Idiopathic Parkinson Disease

Interventions

DRUG: Tozadenant

Sponsor

Biotie Therapies Inc.

Collaborators

[object Object]